Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $596.3500 (-1.24%) ($596.0000 - $596.3500) on Fri. Aug. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 38 | Latest Price | $596.3500(-1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) DIA(36%) IWD(34%) SPLV(33%) SPY(32%) | Factors Impacting REGN price | REGN will decline at least -0.995% in a week (0% probabilities). TBT(-9%) VIXM(-7%) UUP(-5%) VXX(-1%) SHY(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | -2.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $616.32 | 5 Day Moving Average | $603.46(-1.18%) | 10 Day Moving Average | $617.84(-3.48%) | 20 Day Moving Average | $616.32(-3.24%) | To recent high | -13.8% | To recent low | 8.9% | Market Cap | $63.23b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |